EXHIBIT A1 Clause Samples
The "EXHIBIT A1" clause serves as a reference to an attached document or schedule that forms part of the main agreement. Typically, Exhibit A1 contains detailed information such as technical specifications, pricing, deliverables, or other supplemental terms relevant to the contract. By incorporating Exhibit A1, the agreement ensures that all parties have a clear and accessible record of specific details, reducing ambiguity and supporting the enforceability of the contract's provisions.
EXHIBIT A1. This Exhibit A1 shall apply to the purchase of Product designated in this Exhibit by NeuroPace, Inc., a Delaware corporation located at ▇▇▇ ▇. ▇▇▇▇▇▇▇▇ Avenue, Mountain View, California, 94043 USA (“NeuroPace,” referred to as “COMPANY” in the Supply Agreement and “Customer” in the Supplier Quality Agreement) from the following MST Company: Micro Systems Engineering, Inc. (MSEI), [***] (one of the entities referred to as an “MST Affiliate” in the Supply Agreement, and as “Supplier” in the Supplier Quality Agreement).
EXHIBIT A1. RESEARCH AND DEVELOPMENT DIRECT COSTS The following is a list of the types of expenses which are considered as "direct" in Exhibit A and would be billable to ASTI when they can be directly identified with ASTI research and development: Collaborative research agreement payments Payments for compound supply Payments for biologicals Payments for chemical precursors Payment for clinical studies Payment for toxicological, pharmacokinetic studies and other outside services Payment for other Allergan functions (non-R&D) which provide services Payment for research grants Payment for consulting services Hiring expenses for people who will work predominantly on ASTI projects Milestone payments to third parties Project travel, entertainment and related expenses Capital equipment purchased exclusively for ASTI projects Miscellaneous project expenses Regulatory and filing fees Telephone and communications Patent and trademark expenses Software
EXHIBIT A1. For and in consideration of the payments and other benefits due to (the “Executive”) pursuant to the Employment Agreement dated as of October , 2008 (the “Employment Agreement”), by and between MCG Capital Corporation, (the “Company”) and the Executive, and for other good and valuable consideration, the Executive hereby agrees, for the Executive, the Executive’s spouse and child or children (if any), the Executive’s heirs, beneficiaries, devisees, executors, administrators, attorneys, personal representatives, successors and assigns, to forever release, discharge and covenant not to ▇▇▇ the Company or any of its divisions, affiliates, subsidiaries, parents, branches, predecessors, successors, assigns, and, with respect to such entities, their officers, directors, trustees, employees, agents, shareholders, administrators, general or limited partners, representatives, attorneys, insurers and fiduciaries, past, present and future (the “Released Parties”) from any and all claims of any kind arising out of, or related to, his employment with the Company, its affiliates and subsidiaries (collectively, with the Company, the “Affiliated Entities”), the Executive’s separation from employment with the Affiliated Entities, which the Executive now has or may have against the Released Parties, whether known or unknown to the Executive, by reason of facts which have occurred on or prior to the date that the Executive has signed this Release. Such released claims include, without limitation, any and all claims relating to the foregoing under federal, state or local laws pertaining to employment, including, without limitation, the Age Discrimination in Employment Act, Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. Section 2000e et. seq., the Fair Labor Standards Act, as amended, 29 U.S.C. Section 201 et. seq., the Americans with Disabilities Act, as amended, 42 U.S.C. Section 12101 et. seq. the Reconstruction Era Civil Rights Act, as amended, 42 U.S.C. Section 1981 et. seq., the Rehabilitation Act of 1973, as amended, 29 U.S.C. Section 701 et. seq., the Family and Medical Leave Act of 1992, 29 U.S.C. Section 2601 et. seq., and any and all state or local laws regarding employment discrimination and/or federal, state or local laws of any type or description regarding employment, including but not limited to any claims arising from or derivative of the Executive’s employment with the Affiliated Entities, as well as any and all such claims under state contra...
EXHIBIT A1. Remove and replace, in its entirety, the "Aircraft Configuration for 777-200ER Aircraft (applicable to Table 4 Aircraft) Exhibit A1", with the "Aircraft Configuration for 777-200ER Aircraft (applicable to Table 4 Aircraft) Exhibit A1", attached hereto, to reflect the changes made by this Supplemental Agreement No. 14.
EXHIBIT A1. SUBSTANCE USE DISORDERS TREATMENT
EXHIBIT A1. For and in consideration of the payments and other benefits due to ▇▇▇▇ ▇▇▇▇▇▇▇ (the “Executive”) pursuant to the Amended and Restated Employment Agreement effective as of July 30, 2012 (the “Employment Agreement”), by and between MAKO Surgical Corp. (the “Company”) and the Executive, and for other good and valuable consideration, the Executive hereby agrees, for the Executive, the Executive’s spouse and child or children (if any), the Executive’s heirs, beneficiaries, devisees, executors, administrators, attorneys, personal representatives, successors and assigns, to forever release, discharge and covenant not to ▇▇▇ the Company, or any of its divisions, affiliates, subsidiaries, parents, branches, predecessors, successors, assigns, and, with respect to such entities, their officers, directors, trustees, employees, agents, shareholders, administrators, general or limited partners, representatives, attorneys, insurers and fiduciaries, past, present and future (the “Released Parties”) from any and all claims of any kind arising out of, or related to, his employment with the Company, its affiliates and subsidiaries (collectively, with the Company, the “Affiliated Entities”) or the Executive’s separation from employment with the Affiliated Entities, which the Executive now has or may have against the Released Parties, whether known or unknown to the Executive, by reason of facts which have occurred on or prior to the date that the Executive has signed this Release. Such released claims include, without limitation, any and all claims relating to the foregoing under federal, state or local laws pertaining to employment, including, without limitation, the Age Discrimination in Employment Act, Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. Section 2000e et. seq., the Fair Labor Standards Act, as amended, 29 U.S.C. Section 201 et. seq., the Americans with Disabilities Act, as amended, 42 U.S.C. Section 12101 et. seq. the Reconstruction Era Civil Rights Act, as amended, 42 U.S.C. Section 1981 et. seq., the Rehabilitation Act of 1973, as amended, 29 U.S.C. Section 701 et. seq., the Family and Medical Leave Act of 1992, 29 U.S.C. Section 2601 et. seq., and any and all state or local laws regarding employment discrimination and/or federal, state or local laws of any type or description regarding employment, including but not limited to any claims arising from or derivative of the Executive’s employment with the Affiliated Entities, as well as any and...